We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+42.24%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$431M
AUM Growth
+$40.6M
Cap. Flow
-$22.4M
Cap. Flow %
-5.2%
Top 10 Hldgs %
39.17%
Holding
104
New
21
Increased
36
Reduced
26
Closed
21

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$12.5M
2
AMGN icon
Amgen
AMGN
+$10.8M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.35M
4
DHR icon
Danaher
DHR
+$3.96M
5
FOCL
EDAP TMS S.A.
FOCL
+$3.61M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$13.2M
2
SDGR icon
Schrodinger
SDGR
+$10.4M
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$9.41M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.05M
5
GNMK
GenMark Diagnostics, Inc
GNMK
+$9.02M

Sector Composition

Rank Sector Weight
1 Healthcare 92.25%
2 Technology 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAS
101
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-110,547
Closed -$371K
GWPH
102
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-81,573
Closed -$9.41M
GNMK
103
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-617,722
Closed -$9.02M
EIDX
104
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
-21,609
Closed -$2.84M
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Parkman Healthcare Partners held 104 positions worth $431M, up 10% from $390M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parkman Healthcare Partners withdrew a net $22.4M in Q1 2021, closing 21 positions and reducing 26 holdings. Its most notable exit was GW Pharmaceuticals Plc American Depositary Shares, an estimated $9.41M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 92% a quarter earlier, followed by Technology.

Against the trend, Parkman Healthcare Partners opened a new position in United Therapeutics worth $12.5M.

  • Parkman Healthcare Partners's largest Q1 2021 buy was United Therapeutics: 74,874 shares worth $12.5M.
  • Parkman Healthcare Partners added most to Alnylam Pharmaceuticals in Q1 2021, an estimated $4.35M increase.
  • Parkman Healthcare Partners's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $13.2M.
  • Parkman Healthcare Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q1 2021, selling an estimated $9.41M.
  • Parkman Healthcare Partners's ten largest holdings make up 39% of its $431M portfolio in Q1 2021.
  • Parkman Healthcare Partners opened 21 new positions and closed 21 in Q1 2021.
  • Parkman Healthcare Partners's portfolio value rose 10% quarter-over-quarter to $431M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2021, filed 14 May 2021.